CompletedPhase 4

Pulp Capping in Primary Molars Using TheraCal (LC)

Egypt40 participantsStarted 2019-09-01

Plain-language summary

A randomized clinical trial that aims to evaluate clinical and radiographic success rates of indirect pulp capping and direct pulp capping in primary molars with reversible pulpitis using a light-cured tri-calcium silicate base material (TheraCal (LC)).

Who can participate

Age range4 Years – 7 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age: 4-7 years.
✓. Free medical history.
✓. Complete physical and mental health.
✓. Patient cooperation
✓. restorable mandibular primary molars

Exclusion criteria

✕. Clinical symptoms or irreversible pulpitis as (spontaneous pain, throbbing pain)
✕. Soft tissue swelling, draining fistula or sinus tracts.
✕. Tenderness to percussion.
✕. Pathological Tooth mobility.
✕. Widening of periodontal membrane space

What they're measuring

recording signs and symptoms through clinical examination

Timeframe: one year follow-up

Trial details

NCT IDNCT05167123

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-11-30

View on ClinicalTrials.gov More Deep Caries trials